Loading data
AMRNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 213.65 m USD | 228.61 m USD | 306.91 m USD | 369.19 m USD | 583.19 m USD |
| Cost of revenue | — | — | — | — | 121.33 m USD |
| Gross profit | 120.87 m USD | 81.38 m USD | 165.54 m USD | 242.48 m USD | 461.86 m USD |
| Research and development expense | 19.81 m USD | 20.87 m USD | 22.22 m USD | 30.41 m USD | 29.31 m USD |
| Selling, general and administrative expense | 115 m USD | 152.31 m USD | 199.94 m USD | 304.42 m USD | 408.33 m USD |
| Operating profit | -50.17 m USD | -91.8 m USD | -67.59 m USD | -105.87 m USD | 10.5 m USD |
| Interest expense | 7 k USD | 7 k USD | 8 k USD | 15 k USD | 129 k USD |
| Profit before tax | -36.05 m USD | -77.2 m USD | -53.67 m USD | -103.81 m USD | 11.29 m USD |
| Income tax expense | 2.75 m USD | 4.98 m USD | 5.44 m USD | 2 m USD | 3.56 m USD |
| Net income (reported basis) | -38.8 m USD | -87 m USD | -55 m USD | -105.8 m USD | 7.7 m USD |
| Net income attributable to common shareholders | -38.8 m USD | -82.18 m USD | -59.11 m USD | -105.8 m USD | 7.73 m USD |
| Basic earnings per share | -0.09 USD/share | -0.2 USD/share | -0.15 USD/share | -0.26 USD/share | 0.02 USD/share |
| Diluted earnings per share | -0.09 USD/share | -0.2 USD/share | -0.15 USD/share | -0.26 USD/share | 0.02 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.